Page de résultat 11 pour Secteur : Soins de santé Industrie : Biotechnologie Marché boursier - Cotations et cours
Liste de toutes les actions et titres avec cours, capitalisations boursières, ratios P/E et BPA
Tous les pays
- {{country.name}}
- Tous les pays
- États-Unis (1012)
- Australie (58)
- L'Autriche (16)
- Belgique (7)
- Brésil (16)
- Canada (83)
- Chine (94)
- Danemark (6)
- Finlande (4)
- France (41)
- Allemagne (738)
- Hong Kong (46)
- Inde (19)
- Irlande (1)
- Israël (19)
- Italie (4)
- Japon (37)
- Mexique (28)
- Pays-Bas (3)
- Nouvelle-Zélande (1)
- Norvège (14)
- Pologne (9)
- Russie (2)
- Corée du Sud (12)
- Espagne (4)
- Suède (70)
- Suisse (11)
- Taïwan (67)
- Thaïlande (2)
- Turquie (1)
- Royaume-Uni (69)
Tous marchés
- {{item.name}}
- Tous marchés
- Amsterdam (3)
- ASX (58)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KOSDAQ (2)
- KSE (10)
- LSE (44)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- NasdaqCM (285)
- NasdaqGM (149)
- NasdaqGS (226)
- NSE (10)
- NYSE (10)
- NYSE American (19)
- NZSE (1)
- Oslo (14)
- OTC Markets EXMKT (112)
- OTC Markets OTCPK (125)
- OTC Markets OTCQB (38)
- OTC Markets OTCQX (8)
- Other OTC (39)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (47)
- Stockholm (70)
- Stuttgart (39)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (23)
Soins de santé (2611)
- {{item.name}}
- Tous secteur
- Soins de santé (2611)
Biotechnologie (2611)
- {{item.name}}
- Toutes les industries
- Biotechnologie (2611)
- Fabricants de médicaments - Général (279)
- Fabricants de médicaments - de spécialité et génériques (1705)
- Plans de soins de santé (57)
- Établissements de soins médicaux (553)
- Détaillants Pharmaceutiques (155)
- Services d'information sur la santé (419)
- Dispositifs médicaux (913)
- Instruments médicaux et des fournitures (501)
- Diagnostiques et Recherche (427)
- Distribution médicale (138)
| Nom Nom | Prix Prix |
24h% 7j Graphique 24h%&7j |
Cap. du marché Cap. du marché | VOL Volume | 24h bas | 24h de haut | Cap. du marché | PER | BPA |
|---|
| Nom Nom | Prix Prix |
24h% 7j Graphique 24h%&7j |
Cap. du marché Cap. du marché | VOL Volume | 24h bas | 24h de haut | Cap. du marché | PER | BPA | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Oxurion NV OXUR.BR | $0.1 0.11 USD |
+1.11
|
$463.93K 507.14K USD | $10K 10.93K USD | $0.1 0.11 USD | $0.1 0.11 USD | $463.93K 507.14K USD | 0.0010 | $97.53 106.61 USD | |
| Nascent Biotech NBIO | $0.0025 — |
0
|
$430.54K — | $43K — | $0.002299 — | $0.0025 — | $430.54K — | 0 | $0 — | |
| Wesana Health WSNAF | $0.02 — |
0
|
$429.91K — | $3K — | $0.04 — | $0.04 — | $429.91K — | 0 | -$0.02 — | |
| NanoSphere Health Sciences Inc. NSHS.CN | $0.05 0.04 USD |
-16.67
|
$513.76K 381.24K USD | $9.19K 6.82K USD | $0.05 0.04 USD | $0.05 0.04 USD | $513.76K 381.24K USD | 0 | -$0.01 -0.007 USD | |
| Endonovo Therapeutics ENDV | $0.0002999 — |
0
|
$329.38K — | $8M — | $0.0002 — | $0.0002 — | $329.38K — | 0 | $0 — | |
| Amarantus BioScience AMBS | $0.0005 — |
0
|
$315.2K — | $100.1K — | $0.0001 — | $0.0001 — | $315.2K — | 0 | -$0.04 — | |
| CNBX Pharmaceuticals CNBX | $0.01 — |
+5.26
|
$311.11K — | $86.19K — | $0.009499 — | $0.01 — | $311.11K — | 0 | $0 — | |
| Virpax Pharmaceuticals VRPX | $0.25 — |
+19.05
|
$310.63K — | $11.58K — | $0.25 — | $0.3099 — | $310.63K — | 0 | -$71 — | |
| Scandion Oncology A/S SCOL.ST | $0.01 0.0011 USD |
+4.39
|
$2.79M 272.7K USD | $2.72M 265.94K USD | $0.01 0.0010 USD | $0.01 0.0012 USD | $2.79M 272.7K USD | 0 | -$0.24 -0.02 USD | |
| GlobeStar Therapeutics GSTC | $0.0002 — |
0
|
$248.22K — | $5.66M — | $0.0002 — | $0.0002 — | $248.22K — | 0 | $0 — | |
| Mera Pharmaceuticals MRPI | $0.0001 — |
0
|
$222.92K — | $4.42M — | $0.0001 — | $0.0001 — | $222.92K — | 0 | $0 — | |
| Neovacs S.A. ALNEV.PA | $0.02 0.02 USD |
-3.52
|
$178.3K 194.91K USD | $332.75K 363.74K USD | $0.02 0.02 USD | $0.02 0.03 USD | $178.3K 194.91K USD | 0 | -$37,997 -41536.07 USD | |
| TransCode Therapeutics RNAZ | $0.27 — |
-23.58
|
$189.73K — | $5.51M — | $0.22 — | $0.3599 — | $189.73K — | 0.000048 | $5.57K — | |
| BioLineRx Ltd. BLRX.TA | $1.8 0.0052 USD |
+12.5
|
$40.19M 117.18K USD | $6.66M 19.43K USD | $1.7 0.0049 USD | $1.8 0.0052 USD | $40.19M 117.18K USD | 0 | -$0.04 -0.0001 USD | |
| Innovation Pharmaceuticals IPIX | $0.0002 — |
0
|
$103.67K — | $5K — | $0.0002 — | $0.0002 — | $103.67K — | 0 | -$0.01 — | |
| Can-Fite BioPharma Ltd. CANF.TA | $1.6 0.0046 USD |
-5.88
|
$29.26M 85.33K USD | $7.73M 22.53K USD | $1.6 0.0046 USD | $1.7 0.0049 USD | $29.26M 85.33K USD | 0 | $0 0 USD | |
| GB Sciences GBLX | $0.0002 — |
0
|
$81.41K — | $250 — | $0.0002 — | $0.0002 — | $81.41K — | 0 | $0 — | |
| U.S. Stem Cell USRM | $0.0001 — |
0
|
$64.15K — | $10.99K — | $0.0001 — | $0.0001 — | $64.15K — | 0 | $0 — | |
| Calithera Biosciences CALA | $0.005 — |
0
|
$24.36K — | $200 — | $0.0001 — | $0.0001 — | $24.36K — | 0 | -$66.17 — | |
| Better Therapeutics BTTX | $0.0004 — |
0
|
$21.81K — | $151 — | $0.0002999 — | $0.0002999 — | $21.81K — | 0 | -$1.1 — | |
| Q BioMed QBIO | $0.0001 — |
0
|
$14.51K — | $1K — | $0.0001 — | $0.0001 — | $14.51K — | 0 | -$0.02 — | |
| Statera Biopharma STAB | $0.0001 — |
0
|
$7.14K — | $600 — | $0.0001 — | $0.0001 — | $7.14K — | 0 | -$2.36 — | |
| Molecular Templates MTEM | $0.0001 — |
0
|
$658 — | $3 — | $0.0001 — | $0.0001 — | $658 — | 0 | -$3.05 — | |
| NLS Pharmaceutics NLSPW | $0.004499 — |
0
|
$0 — | $3 — | $0.004499 — | $0.004499 — | $0 — | 0 | $0 — | |
| Novo Nordisk A/S N1VO34.SA | $42.23 8.56 USD |
-7.98
|
$1.67T 339.43B USD | $13.89K 2.81K USD | $42.05 8.52 USD | $43.23 8.76 USD | $1.67T 339.43B USD | 16.69 | $2.53 0.51 USD | |
| Novo Nordisk A/S NOVA.F | $51 55.75 USD |
-6.42
|
$250.42B 273.75B USD | $4.01K 4.38K USD | $51 55.75 USD | $56.4 61.65 USD | $250.42B 273.75B USD | 16.83 | $3.03 3.31 USD | |
| Novo Nordisk A/S NVON.MX | $1,250 74.02 USD |
-5.7
|
$2.88T 170.69B USD | $941 55.72 USD | $1,250 74.02 USD | $1,285 76.09 USD | $2.88T 170.69B USD | 20.13 | $62.09 3.68 USD | |
| Vertex Pharmaceuticals Incorporated VRTX.MX | $10,061.9 595.79 USD |
0
|
$2.59T 153.17B USD | $79 4.68 USD | $10,061.9 595.79 USD | $10,061.9 595.79 USD | $2.59T 153.17B USD | 0 | -$42.25 -2.5 USD | |
| Vertex Pharmaceuticals Incorporated VRTX34.SA | $711.41 144.19 USD |
-0.86
|
$737.88B 149.56B USD | $3 0.61 USD | $711.41 144.19 USD | $711.41 144.19 USD | $737.88B 149.56B USD | 0 | -$3.06 -0.6 USD | |
| Vertex Pharmaceuticals Incorporated VX1.DE | $430.2 470.27 USD |
-1.19
|
$110.6B 120.9B USD | $118 128.99 USD | $427.2 466.99 USD | $430.45 470.54 USD | $110.6B 120.9B USD | 0 | -$1.81 -1.9 USD | |
| Vertex Pharmaceuticals Incorporated VRTX.VI | $429.6 469.61 USD |
-1.31
|
$110.44B 120.73B USD | $14 15.3 USD | $428.8 468.74 USD | $432.45 472.73 USD | $110.44B 120.73B USD | 0 | -$1.85 -2.02 USD | |
| Vertex Pharmaceuticals Incorporated VX1.F | $427.7 467.53 USD |
-1.99
|
$110.34B 120.62B USD | $87 95.1 USD | $427.7 467.53 USD | $427.7 467.53 USD | $110.34B 120.62B USD | 0 | -$1.84 -2.01 USD | |
| CSL CMXHF | $147.51 — |
0
|
$73.81B — | $526 — | $155 — | $155 — | $73.81B — | 27.11 | $5.44 — | |
| Regeneron Pharmaceuticals, Inc. REGN.MX | $11,544.79 683.59 USD |
<0.01
|
$1.24T 73.49B USD | $0 0 USD | $11,544.79 683.59 USD | $11,544.79 683.59 USD | $1.24T 73.49B USD | 14.94 | $772.35 45.73 USD | |
| Regeneron Pharmaceuticals, Inc. REGN34.SA | $55.72 11.29 USD |
0
|
$361.3B 73.23B USD | $0 0 USD | $55.72 11.29 USD | $55.72 11.29 USD | $361.3B 73.23B USD | 14.85 | $3.75 0.76 USD | |
| CSL Limited CSJ.F | $132.98 145.37 USD |
-0.4
|
$64.77B 70.81B USD | $10 10.93 USD | $132.64 144.99 USD | $132.98 145.37 USD | $64.77B 70.81B USD | 27.76 | $4.79 5.24 USD | |
| CSL Limited CSJA.F | $66 72.15 USD |
0
|
$64.77B 70.81B USD | $6 6.56 USD | $66 72.15 USD | $66 72.15 USD | $64.77B 70.81B USD | 27.61 | $2.39 2.61 USD | |
| Regeneron Pharmaceuticals, Inc. REGN.VI | $490 535.64 USD |
-0.18
|
$54.03B 59.06B USD | $17 18.58 USD | $480.2 524.92 USD | $490.6 536.29 USD | $54.03B 59.06B USD | 14.42 | $33.96 37.12 USD | |
| Samsung Biologics Co.,Ltd. 207940.KS | $1,049,000 791.82 USD |
-0.94
|
$74.66T 56.36B USD | $28.59K 21.58 USD | $1,046,000 789.56 USD | $1,062,000 801.64 USD | $74.66T 56.36B USD | 0 | $0 0 USD | |
| Seagen Inc. S1GE34.SA | $56.7 11.49 USD |
0
|
$214.37B 43.45B USD | $0 0 USD | $0 0 USD | $0 0 USD | $214.37B 43.45B USD | 0 | $0 0 USD | |
| argenx SE A1RG34.SA | $139.72 28.32 USD |
0
|
$214.04B 43.38B USD | $0 0 USD | $139.72 28.32 USD | $139.72 28.32 USD | $214.04B 43.38B USD | 46.57 | $3 0.61 USD | |
| Seagen SGEN | $228.74 — |
0
|
$43.15B — | $0 — | $0 — | $0 — | $43.15B — | 0 | $0 — | |
| Seagen Inc. SGT.F | $208.6 228.03 USD |
0
|
$39.36B 43.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $39.36B 43.02B USD | 0 | $0 0 USD | |
| argenx SE ARGNF | $697.42 — |
0
|
$42.58B — | $5 — | $695.15 — | $695.15 — | $42.58B — | 54.65 | $12.76 — | |
| Seagen Inc. SGEN.MX | $3,711.48 219.77 USD |
0
|
$700.22B 41.46B USD | $0 0 USD | $0 0 USD | $0 0 USD | $700.22B 41.46B USD | 0 | $0 0 USD | |
| Alnylam Pharmaceuticals, Inc. A1LN34.SA | $67.99 13.78 USD |
0
|
$178.15B 36.11B USD | $0 0 USD | $67.99 13.78 USD | $67.99 13.78 USD | $178.15B 36.11B USD | 0 | -$0.64 -0.1 USD | |
| argenx SE 1AEA.F | $510 557.5 USD |
-1.92
|
$31.96B 34.94B USD | $6 6.56 USD | $510 557.5 USD | $510 557.5 USD | $31.96B 34.94B USD | 45.45 | $11.22 12.26 USD | |
| argenx SE ARGX.VI | $521.4 569.96 USD |
-1.25
|
$31.96B 34.94B USD | $0 0 USD | $519.2 567.56 USD | $521.4 569.96 USD | $31.96B 34.94B USD | 46.10 | $11.31 12.36 USD | |
| argenx SE 1AE.F | $521.2 569.74 USD |
-0.95
|
$31.96B 34.94B USD | $5 5.47 USD | $521.2 569.74 USD | $521.2 569.74 USD | $31.96B 34.94B USD | 46.49 | $11.21 12.25 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.DE | $227.2 248.36 USD |
0
|
$27.27B 29.81B USD | $0 0 USD | $0 0 USD | $0 0 USD | $27.27B 29.81B USD | 0 | $0 0 USD | |
| UCB SA UCBJF | $150.7 — |
0
|
$29.7B — | $100 — | $150.7 — | $150.7 — | $29.7B — | 24.34 | $6.19 — | |
| Alnylam Pharmaceuticals, Inc. DUL.F | $203.2 222.13 USD |
+1.4
|
$26.64B 29.12B USD | $30 32.79 USD | $203.2 222.13 USD | $203.2 222.13 USD | $26.64B 29.12B USD | 0 | -$1.91 -2.08 USD | |
| UCB SA UCB.VI | $135.85 148.5 USD |
-2.02
|
$26.3B 28.75B USD | $0 0 USD | $134.9 147.46 USD | $138.05 150.91 USD | $26.3B 28.75B USD | 24.83 | $5.47 5.98 USD | |
| UCB SA UNC0.F | $67.5 73.79 USD |
-2.17
|
$26.3B 28.75B USD | $50 54.66 USD | $67.5 73.79 USD | $67.5 73.79 USD | $26.3B 28.75B USD | 24.63 | $2.74 3 USD | |
| UCB SA UNC.F | $138.1 150.96 USD |
-2.06
|
$26.3B 28.75B USD | $15 16.4 USD | $138.1 150.96 USD | $138.1 150.96 USD | $26.3B 28.75B USD | 25.20 | $5.48 5.99 USD | |
| BioNTech SE B1NT34.SA | $35.43 7.18 USD |
-0.34
|
$139.32B 28.24B USD | $144 29.19 USD | $35.4 7.17 USD | $36.1 7.32 USD | $139.32B 28.24B USD | 0 | -$1.16 -0.2 USD | |
| BioNTech SE 0A3M.IL | $96.75 — |
-1.28
|
$26.61B — | $844 — | $96.84 — | $98.35 — | $26.61B — | 5.37 | $18 — | |
| Celltrion, Inc. 068270.KS | $157,400 118.81 USD |
-1.13
|
$34.27T 25.87B USD | $411.64K 310.72 USD | $156,400 118.06 USD | $159,200 120.17 USD | $34.27T 25.87B USD | 0 | $0 0 USD | |
| BeiGene, Ltd. 49B.F | $15.34 16.76 USD |
+0.07
|
$23.57B 25.77B USD | $100 109.31 USD | $15.34 16.76 USD | $15.34 16.76 USD | $23.57B 25.77B USD | 0 | -$0.41 -0.4 USD | |
| BeiGene, Ltd. 49BA.F | $202 220.81 USD |
0
|
$23.57B 25.77B USD | $20 21.86 USD | $202 220.81 USD | $202 220.81 USD | $23.57B 25.77B USD | 0 | -$5.35 -5.8 USD | |
| BeiGene, Ltd. B1GN34.SA | $44.65 9.05 USD |
0
|
$123.42B 25.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $123.42B 25.02B USD | 0 | $0 0 USD | |
| Genmab A/S GE9.DE | $331 361.83 USD |
0
|
$21.66B 23.68B USD | $0 0 USD | $0 0 USD | $0 0 USD | $21.66B 23.68B USD | 0 | $0 0 USD | |
| BioNTech SE BNTX.VI | $85.35 93.3 USD |
-1.78
|
$20.83B 22.77B USD | $0 0 USD | $85.35 93.3 USD | $86.65 94.72 USD | $20.83B 22.77B USD | 0 | -$2.77 -3.02 USD | |
| BioNTech SE 22UA.F | $86.05 94.06 USD |
+1.24
|
$20.83B 22.77B USD | $223 243.77 USD | $85.5 93.46 USD | $86.9 94.99 USD | $20.83B 22.77B USD | 0 | -$2.77 -3.02 USD | |
| BeiGene BGNE | $184.72 — |
0
|
$20.21B — | $0 — | $0 — | $0 — | $20.21B — | 0 | $0 — | |
| Royalty Pharma plc RPD.F | $28.24 30.87 USD |
+0.28
|
$16.43B 17.96B USD | $3 3.28 USD | $28.24 30.87 USD | $28.3 30.94 USD | $16.43B 17.96B USD | 16.80 | $1.68 1.84 USD | |
| Royalty Pharma plc RPD.MU | $28.29 30.92 USD |
+0.32
|
$16.43B 17.96B USD | $0 0 USD | $28.29 30.92 USD | $28.29 30.92 USD | $16.43B 17.96B USD | 16.94 | $1.67 1.83 USD | |
| BioMarin Pharmaceutical Inc. BMRN.MX | $1,480 87.63 USD |
0
|
$283.8B 16.8B USD | $0 0 USD | $1,480 87.63 USD | $1,480 87.63 USD | $283.8B 16.8B USD | 33.22 | $44.55 2.64 USD | |
| BioMarin Pharmaceutical Inc. BM8.DE | $81.02 88.57 USD |
0
|
$15.26B 16.68B USD | $0 0 USD | $0 0 USD | $0 0 USD | $15.26B 16.68B USD | 0 | $0 0 USD | |
| Incyte Corporation I1NC34.SA | $209 42.36 USD |
0
|
$80.89B 16.4B USD | $0 0 USD | $209 42.36 USD | $209 42.36 USD | $80.89B 16.4B USD | 475.00 | $0.44 0.09 USD | |
| Incyte Corporation INCY.MX | $1,430.49 84.7 USD |
0
|
$276.83B 16.39B USD | $0 0 USD | $1,430.49 84.7 USD | $1,430.49 84.7 USD | $276.83B 16.39B USD | 476.82 | $3 0.18 USD | |
| BioMarin Pharmaceutical Inc. B1MR34.SA | $208.72 42.3 USD |
0
|
$80.05B 16.22B USD | $0 0 USD | $208.72 42.3 USD | $208.72 42.3 USD | $80.05B 16.22B USD | 32.16 | $6.49 1.32 USD | |
| Insmed Incorporated IM8N.F | $61.5 67.23 USD |
-0.81
|
$11.59B 12.67B USD | $10 10.93 USD | $61.5 67.23 USD | $61.5 67.23 USD | $11.59B 12.67B USD | 0 | -$4.89 -5.3 USD | |
| Insmed Incorporated IM8N.SG | $63 68.87 USD |
+5
|
$11.59B 12.67B USD | $0 0 USD | $62 67.77 USD | $63 68.87 USD | $11.59B 12.67B USD | 0 | -$4.89 -5.3 USD | |
| Karuna Therapeutics KRTX | $329.83 — |
0
|
$12.6B — | $0 — | $0 — | $0 — | $12.6B — | 0 | $0 — | |
| Genmab A/S GNMSF | $200.6 — |
0
|
$12.55B — | $182 — | $197 — | $197 — | $12.55B — | 10.93 | $18.35 — | |
| Karuna Therapeutics, Inc. KRTX.MX | $3,226.17 191.03 USD |
0
|
$209.06B 12.38B USD | $0 0 USD | $0 0 USD | $0 0 USD | $209.06B 12.38B USD | 0 | $0 0 USD | |
| United Therapeutics Corporation UTH.F | $251.6 275.03 USD |
+2.86
|
$11.3B 12.35B USD | $20 21.86 USD | $251.6 275.03 USD | $251.6 275.03 USD | $11.3B 12.35B USD | 11.64 | $21.61 23.62 USD | |
| Genmab A/S GMAB.VI | $173.9 190.1 USD |
-0.14
|
$10.88B 11.9B USD | $0 0 USD | $173.4 189.55 USD | $173.9 190.1 USD | $10.88B 11.9B USD | 10.69 | $16.26 17.77 USD | |
| Ascendis Pharma A/S A1SN34.SA | $54.36 11.02 USD |
0
|
$58.24B 11.8B USD | $0 0 USD | $54.36 11.02 USD | $54.36 11.02 USD | $58.24B 11.8B USD | 0 | -$43.67 -8.8 USD | |
| Moderna, Inc. MRNA.MX | $503.7 29.83 USD |
-7.33
|
$194.74B 11.53B USD | $1.8K 106.64 USD | $500 29.61 USD | $515 30.49 USD | $194.74B 11.53B USD | 0 | -$186.9 -11.06 USD | |
| WuXi Biologics (Cayman) WXIBF | $2.74 — |
0
|
$11.09B — | $5.4K — | $2.74 — | $2.74 — | $11.09B — | 24.90 | $0.11 — | |
| BioMarin Pharmaceutical Inc. BMRN.VI | $52 56.84 USD |
-1.07
|
$9.97B 10.9B USD | $0 0 USD | $51.38 56.17 USD | $52.04 56.89 USD | $9.97B 10.9B USD | 26.53 | $1.96 2.14 USD | |
| BioMarin Pharmaceutical Inc. BM8.F | $51.8 56.62 USD |
-0.38
|
$9.96B 10.88B USD | $2 2.19 USD | $51.8 56.62 USD | $51.8 56.62 USD | $9.96B 10.88B USD | 26.70 | $1.94 2.12 USD | |
| Incyte Corporation ICY.F | $50.64 55.36 USD |
-0.78
|
$9.89B 10.81B USD | $6 6.56 USD | $50.64 55.36 USD | $50.64 55.36 USD | $9.89B 10.81B USD | 389.53 | $0.13 0.14 USD | |
| WuXi Biologics (Cayman) Inc. 1FW1.F | $4.6 5.03 USD |
+2.68
|
$9.38B 10.25B USD | $10 10.93 USD | $4.6 5.03 USD | $4.6 5.03 USD | $9.38B 10.25B USD | 24.21 | $0.19 0.21 USD | |
| Exelixis, Inc. EX9.F | $31.66 34.61 USD |
+0.48
|
$8.75B 9.57B USD | $92 100.57 USD | $31.66 34.61 USD | $31.66 34.61 USD | $8.75B 9.57B USD | 20.42 | $1.55 1.69 USD | |
| Ascendis Pharma A/S A71.F | $140 153.04 USD |
+6.06
|
$8.71B 9.52B USD | $50 54.66 USD | $140 153.04 USD | $140 153.04 USD | $8.71B 9.52B USD | 0 | -$6.52 -7.1 USD | |
| Innovent Biologics, Inc. 6IB.F | $5.25 5.74 USD |
+3.96
|
$8.7B 9.51B USD | $6.56K 7.17K USD | $5.25 5.74 USD | $5.3 5.79 USD | $8.7B 9.51B USD | 0 | -$0.01 -0.01 USD | |
| Moderna, Inc. 0QF.MU | $22.48 24.57 USD |
-0.64
|
$8.69B 9.5B USD | $0 0 USD | $22.48 24.57 USD | $22.48 24.57 USD | $8.69B 9.5B USD | 0 | -$8.14 -8.8 USD | |
| Bio-Techne Corporation T1CH34.SA | $9.85 2 USD |
0
|
$46.71B 9.47B USD | $0 0 USD | $9.85 2 USD | $9.85 2 USD | $46.71B 9.47B USD | 51.84 | $0.19 0.04 USD | |
| Moderna, Inc. MRNA.VI | $21.94 23.98 USD |
-3.31
|
$8.48B 9.27B USD | $8 8.75 USD | $21.94 23.98 USD | $22.49 24.58 USD | $8.48B 9.27B USD | 0 | -$8.22 -8.9 USD | |
| Moderna, Inc. 0QF.F | $21.84 23.87 USD |
-0.75
|
$8.44B 9.23B USD | $91 99.48 USD | $21.8 23.83 USD | $22.22 24.29 USD | $8.44B 9.23B USD | 0 | -$8.14 -8.8 USD | |
| Akeso, Inc. 4RY.F | $9.2 10.06 USD |
-2.13
|
$8.42B 9.2B USD | $233 254.7 USD | $9.2 10.06 USD | $9.35 10.22 USD | $8.42B 9.2B USD | 0 | -$0.07 -0.07 USD | |
| ImmunoGen, Inc. IMU.F | $28.74 31.42 USD |
0
|
$8.08B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $8.08B 8.83B USD | 0 | $0 0 USD | |
| ImmunoGen, Inc. IMGN.MX | $268.5 15.9 USD |
0
|
$149.06B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $149.06B 8.83B USD | 0 | $0 0 USD | |
| ImmunoGen IMGN | $31.23 — |
0
|
$8.72B — | $0 — | $0 — | $0 — | $8.72B — | 0 | $0 — | |
| Sino Biopharmaceutical Limited SBMFF | $0.4699 — |
0
|
$8.46B — | $2.5K — | $0.45 — | $0.45 — | $8.46B — | 46.79 | $0.01 — | |
| Sino Biopharmaceutical SBHMY | $8.79 — |
0
|
$8.46B — | $100 — | $10.3 — | $10.3 — | $8.46B — | 31.39 | $0.28 — | |
| Cerevel Therapeutics CERE | $44.96 — |
0
|
$8.19B — | $0 — | $0 — | $0 — | $8.19B — | 0 | $0 — | |
|
Aucune action favorite
Vous n'avez pas encore d'actions favorites, veuillez l'ajouter aux favoris pour la voir ici |
||||||||||